124 related articles for article (PubMed ID: 21062083)
21. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
Szabó I; Manea M; Orbán E; Csámpai A; Bosze S; Szabó R; Tejeda M; Gaál D; Kapuvári B; Przybylski M; Hudecz F; Mezo G
Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605
[TBL] [Abstract][Full Text] [Related]
22. Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells.
Guo J; Zhou J; Ying X; Men Y; Li RJ; Zhang Y; Du J; Tian W; Yao HJ; Wang XX; Ju RJ; Lu WL
J Pharm Pharm Sci; 2010; 13(2):136-51. PubMed ID: 20816001
[TBL] [Abstract][Full Text] [Related]
23. The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway.
Akiyoshi T; Matzno S; Sakai M; Okamura N; Matsuyama K
Cancer Chemother Pharmacol; 2009 Dec; 65(1):143-50. PubMed ID: 19449007
[TBL] [Abstract][Full Text] [Related]
24. Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3.
Miura T; Chiba M; Kasai K; Nozaka H; Nakamura T; Shoji T; Kanda T; Ohtake Y; Sato T
Carcinogenesis; 2008 Mar; 29(3):585-93. PubMed ID: 17827407
[TBL] [Abstract][Full Text] [Related]
25. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo.
Shimoda S; Ichihara H; Matsumoto Y; Ueoka R
Int J Pharm; 2009 May; 372(1-2):162-8. PubMed ID: 19429276
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
[TBL] [Abstract][Full Text] [Related]
29. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
30. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
31. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
32. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.
Ma X; Zhou J; Zhang CX; Li XY; Li N; Ju RJ; Shi JF; Sun MG; Zhao WY; Mu LM; Yan Y; Lu WL
Biomaterials; 2013 Jun; 34(18):4452-65. PubMed ID: 23518403
[TBL] [Abstract][Full Text] [Related]
33. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
34. Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway.
Hsieh YC; Rao YK; Wu CC; Huang CY; Geethangili M; Hsu SL; Tzeng YM
Chem Res Toxicol; 2010 Jul; 23(7):1256-67. PubMed ID: 20557081
[TBL] [Abstract][Full Text] [Related]
35. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Yang M; Nishio M
Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
37. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
38. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
Lemieux P; Pagé M; Noël C
In Vivo; 1992; 6(6):621-7. PubMed ID: 1296812
[TBL] [Abstract][Full Text] [Related]
39. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
[TBL] [Abstract][Full Text] [Related]
40. HL-37, a novel anthracene derivative, induces Ca(2+)-mediated apoptosis in human breast cancer cells.
Xie SQ; Zhang ZQ; Hu GQ; Xu M; Ji BS
Toxicology; 2008 Dec; 254(1-2):68-74. PubMed ID: 18948164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]